A recent trip to Zambia by Carver College of Medicine delegates shed light on the inspiring work of the House of Hope, an organization transforming care for children with hydrocephalus and spina bifida while combating stigma. With efforts expanding into pediatric eye care and medical education, the journey highlights the power of local partnerships, innovation, and advocacy in addressing healthcare challenges and building sustainable change.

Dr. Stephen Russell recently shared the 8 and 9-year follow-up results of the phase 3 trial of voretigene neparvovec-rzyl (Luxturna) at the American Society of Retina Specialists (ASRS) meeting. This gene therapy, the first approved for any inherited disease, targets a specific type of retinal dystrophy caused by RPE65 mutations.